Brimonidine is a selective alpha-2 adrenergic agonist used topically to reduce intraocular pressure in glaucoma and, in a separate formulation, to lessen facial erythema associated with rosacea. Simson Pharma's Brimonidine reference standard and impurities support compendial testing across both ophthalmic and dermatological uses.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Brimonidine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.